This inventor holds 2 USPTO granted patents. Top assignees: Yunnan Institute of Materia Medica, Hlk Pharmaceuticals Co., Ltd.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yunnan, CN (2019)
- Kunming, CN (2020)
Company Filing History:
2 out of 2 
1 out of 1 Years Active: 2019-2020
Title: Biography of Inventor Tao Cui
Introduction
Tao Cui is a notable inventor based in Yunnan, China. He has made significant contributions to the fields of medicine and chemical industry through his innovative research and inventions. With a total of 2 patents to his name, he has focused on developing new methods and applications for various compounds.
Latest Patents
Tao Cui's latest patents include the "Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof." This application discloses five polymorph forms of a specific compound, which is aimed at preventing or treating mood disorders or diseases related to the δ opioid receptor. Another significant patent is for the "Crystal forms of scutellarin aglycone and preparation thereof." This invention addresses the stability and bioavailability issues of scutellarin, making it useful in the manufacture of medications for cardiovascular or cerebrovascular diseases, rheumatic arthritis, and stroke sequelae.
Career Highlights
Throughout his career, Tao Cui has worked with esteemed organizations such as the Yunnan Institute of Materia Medica and Hlk Pharmaceuticals Co., Ltd. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Tao Cui has collaborated with several professionals in his field, including Zeren Wang and Zhaoyun Zhu. These collaborations have further enriched his research and contributed to
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile